Sentara Recalls Invanz Injection Homepumps Due to Sterility Concerns
Sentara Enterprises is recalling specific lots of Invanz (ertapenem) injection homepumps because product sterility cannot be guaranteed. The affected products were distributed in Virginia and North Carolina.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving potential adverse health consequences (such as sterility issues in injectable drugs) are categorized as Severe (Score 4), especially given the lack of reported illnesses which prevents a higher classification but the inherent risk of non-sterile injectables.
Plain-English summary
Sentara Enterprises is recalling Invanz (ertapenem) Injection Recon Soln in NS, packaged as 500mg in 50ml and 1gm in 100ml homepumps. The recall is due to a lack of assurance of sterility, meaning the product's sterility cannot be guaranteed. The affected lots were compounded between September 11, 2015, and September 17, 2015.
The recall involves 3 bags of the 500mg formulation and 60 bags of the 1gm formulation. These products were distributed in the United States, specifically in Virginia and North Carolina. The expiration dates for the affected lots range from September 19, 2015, to September 25, 2015.
Consumers and healthcare providers should stop using the affected products and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Invanz (ertapenem) Injection Recon Soln in NS, Packaged as a) 500MG in 50ML Homepumps and b) 1 GM in 100ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.
- Manufacturer
- Sentara Enterprises
- Category
- Drug — Injectable Antibiotic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 22-Sep-15
- b) 19-Sep-15
- 20-Sep-15
- 22-Sep-15
- 23-Sep-15
- 24-Sep-15
- 25-Sep-15
Distribution
Part of a larger recall action
This product is one of 34 recalled by Sentara Enterprises under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 34 products in this recall →Related recalls
Same manufacturer · Sentara Enterprises
See all →- SevereSentara Recalls Nafcillin Bags Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-02-03
- HighSentara Recalls Sodium Chloride Homepumps Due to Sterility Concerns
FDA (Drugs) · 2016-02-03
- SevereSentara Recalls Tobramycin Homepumps Due to Sterility Concerns
FDA (Drugs) · 2016-02-03
- SevereSentara Recalls Intralipid Fat Emulsion Due to Sterility Assurance Issues
FDA (Drugs) · 2016-02-03
- SevereSentara Recalls Gentamicin Homepumps Due to Sterility Concerns
FDA (Drugs) · 2016-02-03
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29